{
    "hands_on_practices": [
        {
            "introduction": "For a bacteriophage to be effective, it must first reach the site of infection at a sufficient concentration. This exercise introduces a fundamental concept from pharmacology, the apparent volume of distribution ($V_d$), which describes how a therapeutic agent spreads throughout the body after administration. By calculating the expected plasma concentration, and then adjusting for real-world phenomena like sequestration by the immune system, you will gain a quantitative understanding of the initial pharmacokinetic challenges in phage therapy .",
            "id": "4612349",
            "problem": "A bacteriophage preparation is administered as an intravenous bolus to a patient for therapeutic control of a multidrug-resistant bacterial infection. Consider a short early time window after injection during which elimination and bacterial amplification are negligible, and the drug behaves according to a single well-mixed compartment. Use the core definition of volume of distribution, namely that at distribution equilibrium the volume of distribution $V_d$ satisfies $V_d = \\frac{A_{\\text{total}}}{C_p}$, where $A_{\\text{total}}$ is the amount of agent in the body and $C_p$ is the plasma concentration. In this initial window after bolus injection, assume $A_{\\text{total}} \\approx D$, where $D$ is the administered dose.\n\nGiven an apparent volume of distribution $V_d = 4.5~\\mathrm{L}$ and an injected dose $D = 3.0 \\times 10^{10}~\\mathrm{PFU}$ (plaque-forming units), estimate the expected initial plasma concentration $C_{p,0}$ from first principles. Then, incorporate the effect of rapid tissue sequestration: suppose a fraction $s = 0.25$ of the injected phage dose is transiently sequestered by the reticuloendothelial system (RES) and bacterial biofilms and does not contribute to the circulating plasma during this window. Starting from the same definition, derive the corrected initial plasma concentration $C_{p,0}^{\\text{corr}}$ that accounts for sequestration.\n\nExpress your final answer as the corrected initial plasma concentration in $\\mathrm{PFU}/\\mathrm{mL}$. Round your answer to three significant figures. Briefly justify within your derivation how tissue sequestration modifies the estimate using the fundamental definitions provided, without invoking unintroduced shortcut formulas.",
            "solution": "The user wants me to solve a problem based on the principles of pharmacokinetics, specifically concerning bacteriophage therapy.\n\n### Step 1: Extract Givens\n- Definition of Volume of Distribution: $V_d = \\frac{A_{\\text{total}}}{C_p}$\n- Assumption 1 (initial estimate): Total amount of agent in the body $A_{\\text{total}} \\approx$ Administered dose $D$.\n- Assumption 2 (corrected estimate): A fraction $s$ of the dose is sequestered and does not contribute to circulating plasma.\n- Apparent volume of distribution: $V_d = 4.5~\\mathrm{L}$\n- Injected dose: $D = 3.0 \\times 10^{10}~\\mathrm{PFU}$\n- Sequestered fraction: $s = 0.25$\n- Goal 1: Estimate the initial plasma concentration, $C_{p,0}$.\n- Goal 2: Derive the corrected initial plasma concentration, $C_{p,0}^{\\text{corr}}$, accounting for sequestration.\n- Final Answer Format: Express $C_{p,0}^{\\text{corr}}$ in $\\mathrm{PFU}/\\mathrm{mL}$, rounded to three significant figures.\n\n### Step 2: Validate Using Extracted Givens\nThe problem is validated against the required criteria.\n- **Scientifically Grounded**: The problem is based on fundamental and standard principles of pharmacokinetics, namely the concept of the volume of distribution ($V_d$), dose ($D$), and plasma concentration ($C_p$). The scenario, involving bacteriophage therapy and sequestration by the reticuloendothelial system (RES), is scientifically realistic and relevant to modern medical microbiology and pharmacology.\n- **Well-Posed**: The problem provides all necessary definitions, variables ($D$, $V_d$, $s$), and a clear objective. The premises lead to a unique and meaningful solution.\n- **Objective**: The problem is stated in precise, quantitative, and unbiased language.\n- **Completeness and Consistency**: The provided data are self-consistent and sufficient for solving the problem. There are no contradictions. The structure of the problem (calculating an initial estimate, then a corrected one) is logical.\n\n### Step 3: Verdict and Action\nThe problem is valid. I will now proceed with the solution.\n\nThe solution will be derived from the fundamental definition of the volume of distribution provided in the problem statement. The volume of distribution, $V_d$, is an apparent volume that relates the total amount of a drug in the body to its concentration in blood plasma.\n\nFirst, we calculate the initial, uncorrected plasma concentration, $C_{p,0}$. The problem states to use the definition $V_d = \\frac{A_{\\text{total}}}{C_p}$ and the assumption that the total amount of agent in the body, $A_{\\text{total}}$, is approximately equal to the administered dose, $D$. At the initial time point ($t=0$), the plasma concentration is $C_{p,0}$.\n\n$$V_d = \\frac{D}{C_{p,0}}$$\n\nSolving for $C_{p,0}$ gives:\n\n$$C_{p,0} = \\frac{D}{V_d}$$\n\nSubstituting the given values:\n\n$$C_{p,0} = \\frac{3.0 \\times 10^{10}~\\mathrm{PFU}}{4.5~\\mathrm{L}} = \\frac{2}{3} \\times 10^{10}~\\mathrm{PFU}/\\mathrm{L} \\approx 6.67 \\times 10^9~\\mathrm{PFU}/\\mathrm{L}$$\n\nNext, we must incorporate the effect of sequestration to find the corrected initial plasma concentration, $C_{p,0}^{\\text{corr}}$. The problem states that a fraction $s$ of the injected dose is rapidly sequestered and \"does not contribute to the circulating plasma.\" This is the critical piece of information. The apparent volume of distribution, $V_d$, is a proportionality constant that relates the plasma concentration to the amount of drug that is actively involved in the distribution equilibrium within the body's compartments (the \"well-mixed compartment\").\n\nThe sequestered fraction of the dose, equal to $s \\times D$, is effectively removed from this dynamic process. Therefore, the amount of agent that actually distributes throughout the apparent volume $V_d$ to establish the plasma concentration is not the total dose $D$, but the non-sequestered portion.\n\nLet $A_{\\text{effective}}$ be the amount of drug that contributes to the plasma concentration.\n$$A_{\\text{effective}} = D - (s \\times D) = D(1-s)$$\n\nWe now apply the fundamental definition of $V_d$ using this effective amount. The volume of distribution $V_d$ relates this effective amount to the resulting corrected plasma concentration $C_{p,0}^{\\text{corr}}$.\n\n$$V_d = \\frac{A_{\\text{effective}}}{C_{p,0}^{\\text{corr}}}$$\n\nSubstituting the expression for $A_{\\text{effective}}$:\n\n$$V_d = \\frac{D(1-s)}{C_{p,0}^{\\text{corr}}}$$\n\nWe solve for the corrected initial plasma concentration, $C_{p,0}^{\\text{corr}}$:\n\n$$C_{p,0}^{\\text{corr}} = \\frac{D(1-s)}{V_d}$$\n\nNow we substitute the numerical values for $D$, $s$, and $V_d$:\n- $D = 3.0 \\times 10^{10}~\\mathrm{PFU}$\n- $s = 0.25$, so $(1-s) = 0.75$\n- $V_d = 4.5~\\mathrm{L}$\n\n$$C_{p,0}^{\\text{corr}} = \\frac{(3.0 \\times 10^{10}) \\times (0.75)}{4.5} \\frac{\\mathrm{PFU}}{\\mathrm{L}}$$\n$$C_{p,0}^{\\text{corr}} = \\frac{2.25 \\times 10^{10}}{4.5} \\frac{\\mathrm{PFU}}{\\mathrm{L}}$$\n$$C_{p,0}^{\\text{corr}} = 0.5 \\times 10^{10} \\frac{\\mathrm{PFU}}{\\mathrm{L}} = 5.0 \\times 10^9 \\frac{\\mathrm{PFU}}{\\mathrm{L}}$$\n\nThe problem requires the final answer to be in units of $\\mathrm{PFU}/\\mathrm{mL}$. We perform the unit conversion, knowing that $1~\\mathrm{L} = 1000~\\mathrm{mL} = 10^3~\\mathrm{mL}$.\n\n$$C_{p,0}^{\\text{corr}} = 5.0 \\times 10^9 \\frac{\\mathrm{PFU}}{\\mathrm{L}} \\times \\frac{1~\\mathrm{L}}{10^3~\\mathrm{mL}}$$\n$$C_{p,0}^{\\text{corr}} = 5.0 \\times 10^{(9-3)} \\frac{\\mathrm{PFU}}{\\mathrm{mL}}$$\n$$C_{p,0}^{\\text{corr}} = 5.0 \\times 10^6 \\frac{\\mathrm{PFU}}{\\mathrm{mL}}$$\n\nFinally, we round the answer to three significant figures as requested.\n\n$$C_{p,0}^{\\text{corr}} = 5.00 \\times 10^6 \\frac{\\mathrm{PFU}}{\\mathrm{mL}}$$\n\nThis result is physically sensible. The sequestration of a portion of the dose prevents it from circulating, leading to a lower initial plasma concentration ($5.00 \\times 10^6~\\mathrm{PFU}/\\mathrm{mL}$) compared to the naive estimate that ignores sequestration ($\\approx 6.67 \\times 10^6~\\mathrm{PFU}/\\mathrm{mL}$).",
            "answer": "$$\\boxed{5.00 \\times 10^6}$$"
        },
        {
            "introduction": "Many persistent bacterial infections are protected by biofilms, dense communities of bacteria encased in a self-produced matrix that acts as a physical barrier. This exercise explores the critical challenge of phage delivery into these structures using a reaction-diffusion model, which accounts for both phage movement and its inactivation upon binding to bacteria. You will determine the steady-state phage concentration profile within a biofilm and calculate the characteristic penetration depth, a key parameter that dictates whether phages can reach and eliminate bacteria deep inside their stronghold .",
            "id": "4612342",
            "problem": "A planar bacterial biofilm with uniform bacterial number density $B$ is exposed at its surface ($x=0$) to a well-mixed phage reservoir that maintains a constant phage concentration $P_0$. The interior of the biofilm ($x>0$) presents a porous matrix that slows phage movement, leading to an effective diffusion coefficient $D_{\\mathrm{eff}}$. Phage are irreversibly removed by adsorption to bacterial surfaces, which at low phage concentration is well-described by mass-action kinetics with an adsorption rate constant $k$ so that the removal rate is proportional to $k P B$. Assuming one-dimensional transport normal to the surface, the phage concentration $P(x,t)$ is governed by the partial differential equation (PDE) \n$$\\frac{\\partial P}{\\partial t} = D_{\\mathrm{eff}} \\frac{\\partial^2 P}{\\partial x^2} - k P B,$$\nwith boundary conditions $P(0,t) = P_0$ and $P(x,t) \\to 0$ as $x \\to \\infty$, and initial condition $P(x,0)=0$ for $x>0$. \n\nUsing conservation of mass and Fick's second law of diffusion as the fundamental base, derive the steady-state concentration profile $P(x)$ and define the penetration depth $x_{\\mathrm{pen}}$ as the distance into the biofilm at which $P(x)$ falls to $P_0/\\exp(1)$. Then, for\n- $D_{\\mathrm{eff}} = 1.8 \\times 10^{-11}\\ \\mathrm{m}^2\\,\\mathrm{s}^{-1}$,\n- $k = 2.5 \\times 10^{-16}\\ \\mathrm{m}^3\\,\\mathrm{s}^{-1}\\,\\mathrm{cell}^{-1}$,\n- $B = 4.0 \\times 10^{14}\\ \\mathrm{cells}\\,\\mathrm{m}^{-3}$,\n\ncompute $x_{\\mathrm{pen}}$ and express your final result in micrometers. Round your answer to four significant figures.",
            "solution": "The problem will be validated according to the specified procedure.\n\n### Step 1: Extract Givens\n- Governing PDE: $\\frac{\\partial P}{\\partial t} = D_{\\mathrm{eff}} \\frac{\\partial^2 P}{\\partial x^2} - k P B$\n- Domain: $x \\ge 0$\n- Boundary conditions: $P(0,t) = P_0$ and $P(x,t) \\to 0$ as $x \\to \\infty$\n- Initial condition: $P(x,0)=0$ for $x>0$\n- Constant parameters: Bacterial number density $B$, effective diffusion coefficient $D_{\\mathrm{eff}}$, adsorption rate constant $k$.\n- Definition: The penetration depth $x_{\\mathrm{pen}}$ is the distance at which $P(x) = P_0/\\exp(1)$.\n- Numerical values:\n  - $D_{\\mathrm{eff}} = 1.8 \\times 10^{-11}\\ \\mathrm{m}^2\\,\\mathrm{s}^{-1}$\n  - $k = 2.5 \\times 10^{-16}\\ \\mathrm{m}^3\\,\\mathrm{s}^{-1}\\,\\mathrm{cell}^{-1}$\n  - $B = 4.0 \\times 10^{14}\\ \\mathrm{cells}\\,\\mathrm{m}^{-3}$\n- Required output: Compute $x_{\\mathrm{pen}}$ in micrometers, rounded to four significant figures.\n\n### Step 2: Validate Using Extracted Givens\n1.  **Scientifically Grounded**: The problem describes phage transport in a biofilm using a reaction-diffusion equation. This is a standard and well-established model in biophysics and microbiology. The reaction term, $-kPB$, represents first-order removal kinetics (since $B$ is constant), which is a valid simplification of Michaelis-Menten kinetics at low substrate (phage) concentrations. The model is based on Fick's second law and mass-action kinetics, which are fundamental principles. The units provided for the constants are dimensionally consistent. The term $kPB$ must have units of concentration per time ($\\mathrm{phage}\\,\\mathrm{m}^{-3}\\,\\mathrm{s}^{-1}$). The product of the given units is $(\\mathrm{m}^3\\,\\mathrm{s}^{-1}\\,\\mathrm{cell}^{-1}) \\times (\\mathrm{phage}\\,\\mathrm{m}^{-3}) \\times (\\mathrm{cell}\\,\\mathrm{m}^{-3}) = \\mathrm{phage}\\,\\mathrm{m}^{-3}\\,\\mathrm{s}^{-1}$, which is correct. The problem is scientifically sound.\n2.  **Well-Posed**: The problem provides a PDE with well-defined initial and boundary conditions for a semi-infinite domain. The request is for the steady-state solution, which is expected to be unique and stable under these conditions. The problem is well-posed.\n3.  **Objective**: The problem is stated in precise, quantitative, and objective language. It is free from subjective claims.\n4.  **Complete and Consistent**: All necessary parameters and conditions for finding the steady-state solution and the penetration depth are provided. There are no contradictions in the setup.\n\n### Step 3: Verdict and Action\nThe problem is valid as it is scientifically grounded, well-posed, objective, and self-contained. A complete solution will be provided.\n\nThe problem asks for the steady-state concentration profile $P(x)$ and the penetration depth $x_{\\mathrm{pen}}$. At steady state, the concentration does not change with time, which means $\\frac{\\partial P}{\\partial t} = 0$. The partial differential equation (PDE) simplifies to a second-order ordinary differential equation (ODE):\n$$0 = D_{\\mathrm{eff}} \\frac{d^2 P}{d x^2} - k B P$$\nThis can be rearranged into a standard form:\n$$\\frac{d^2 P}{d x^2} - \\frac{k B}{D_{\\mathrm{eff}}} P = 0$$\nThis is a linear, homogeneous, second-order ODE with constant coefficients. Let us define a characteristic length scale $\\lambda$ such that $\\lambda^{-2} = \\frac{kB}{D_{\\mathrm{eff}}}$. Then the equation becomes:\n$$\\frac{d^2 P}{d x^2} - \\frac{1}{\\lambda^2} P = 0$$\nThe characteristic equation is $r^2 - \\frac{1}{\\lambda^2} = 0$, which has two real roots, $r_1 = \\frac{1}{\\lambda}$ and $r_2 = -\\frac{1}{\\lambda}$. The general solution is therefore of the form:\n$$P(x) = C_1 \\exp\\left(\\frac{x}{\\lambda}\\right) + C_2 \\exp\\left(-\\frac{x}{\\lambda}\\right)$$\nWe apply the boundary conditions to determine the constants $C_1$ and $C_2$. The steady-state boundary conditions are $P(0) = P_0$ and $P(x) \\to 0$ as $x \\to \\infty$.\n\nFrom the condition $P(x) \\to 0$ as $x \\to \\infty$, we analyze the general solution. The term $\\exp(x/\\lambda)$ grows indefinitely as $x \\to \\infty$. To satisfy the boundary condition, its coefficient must be zero, so $C_1 = 0$. The solution simplifies to:\n$$P(x) = C_2 \\exp\\left(-\\frac{x}{\\lambda}\\right)$$\nNow, we apply the second boundary condition at the surface, $P(0) = P_0$:\n$$P(0) = C_2 \\exp(0) = C_2 = P_0$$\nThus, the steady-state concentration profile is:\n$$P(x) = P_0 \\exp\\left(-\\frac{x}{\\lambda}\\right)$$\nwhere $\\lambda = \\sqrt{\\frac{D_{\\mathrm{eff}}}{kB}}$.\n\nNext, we find the penetration depth $x_{\\mathrm{pen}}$. It is defined as the distance $x$ at which the phage concentration drops to $P_0/\\exp(1)$, or $P_0 \\exp(-1)$.\n$$P(x_{\\mathrm{pen}}) = P_0 \\exp\\left(-\\frac{x_{\\mathrm{pen}}}{\\lambda}\\right) = P_0 \\exp(-1)$$\nBy comparing the exponents, we find:\n$$-\\frac{x_{\\mathrm{pen}}}{\\lambda} = -1$$\n$$x_{\\mathrm{pen}} = \\lambda$$\nTherefore, the penetration depth is exactly the characteristic length scale $\\lambda$:\n$$x_{\\mathrm{pen}} = \\sqrt{\\frac{D_{\\mathrm{eff}}}{kB}}$$\nNow, we can substitute the given numerical values to compute $x_{\\mathrm{pen}}$.\n- $D_{\\mathrm{eff}} = 1.8 \\times 10^{-11}\\ \\mathrm{m}^2\\,\\mathrm{s}^{-1}$\n- $k = 2.5 \\times 10^{-16}\\ \\mathrm{m}^3\\,\\mathrm{s}^{-1}\\,\\mathrm{cell}^{-1}$\n- $B = 4.0 \\times 10^{14}\\ \\mathrm{cells}\\,\\mathrm{m}^{-3}$\n\nFirst, we calculate the product $kB$:\n$$kB = (2.5 \\times 10^{-16}\\ \\mathrm{m}^3\\,\\mathrm{s}^{-1}\\,\\mathrm{cell}^{-1}) \\times (4.0 \\times 10^{14}\\ \\mathrm{cells}\\,\\mathrm{m}^{-3})$$\n$$kB = (2.5 \\times 4.0) \\times 10^{-16+14}\\ \\mathrm{s}^{-1}$$\n$$kB = 10.0 \\times 10^{-2}\\ \\mathrm{s}^{-1} = 1.0 \\times 10^{-1}\\ \\mathrm{s}^{-1}$$\nNow, we substitute this into the expression for $x_{\\mathrm{pen}}$:\n$$x_{\\mathrm{pen}} = \\sqrt{\\frac{1.8 \\times 10^{-11}\\ \\mathrm{m}^2\\,\\mathrm{s}^{-1}}{1.0 \\times 10^{-1}\\ \\mathrm{s}^{-1}}}$$\n$$x_{\\mathrm{pen}} = \\sqrt{1.8 \\times 10^{-10}\\ \\mathrm{m}^2}$$\n$$x_{\\mathrm{pen}} = \\sqrt{1.8} \\times \\sqrt{10^{-10}}\\ \\mathrm{m}$$\n$$x_{\\mathrm{pen}} = \\sqrt{1.8} \\times 10^{-5}\\ \\mathrm{m}$$\nCalculating the value of $\\sqrt{1.8}$:\n$$\\sqrt{1.8} \\approx 1.3416407865$$\nSo,\n$$x_{\\mathrm{pen}} \\approx 1.3416407865 \\times 10^{-5}\\ \\mathrm{m}$$\nThe problem asks for the result in micrometers ($\\mu\\mathrm{m}$). We use the conversion $1\\ \\mathrm{m} = 10^6\\ \\mu\\mathrm{m}$:\n$$x_{\\mathrm{pen}} \\approx (1.3416407865 \\times 10^{-5}) \\times 10^6\\ \\mu\\mathrm{m}$$\n$$x_{\\mathrm{pen}} \\approx 1.3416407865 \\times 10^1\\ \\mu\\mathrm{m}$$\n$$x_{\\mathrm{pen}} \\approx 13.416407865\\ \\mu\\mathrm{m}$$\nFinally, rounding the result to four significant figures:\n$$x_{\\mathrm{pen}} \\approx 13.42\\ \\mu\\mathrm{m}$$\nThis is the final numerical answer.",
            "answer": "$$\\boxed{13.42}$$"
        },
        {
            "introduction": "Combining multiple phages into a \"cocktail\" is a primary strategy to enhance killing efficacy and combat the rapid evolution of bacterial resistance. However, do the phages work better together than they would alone? This exercise introduces a formal method to assess whether a combination is merely additive or truly synergisticâ€”meaning the whole is greater than the sum of its parts. By applying the Bliss independence model to hypothetical experimental data, you will learn how to quantify phage-phage interactions, a crucial step in designing potent therapeutic cocktails .",
            "id": "4612423",
            "problem": "In a controlled in vitro assay against a single pathogenic bacterial strain, two strictly lytic bacteriophages, denoted phage A and phage B, are applied separately and together at fixed multiplicities of infection (multiplicity of infection (MOI) is the average number of infective units per target cell). For each condition at a fixed timepoint, you measure the fractional kill, defined as the fraction of viable bacteria eliminated relative to a no-phage control at that timepoint. The single-phage measurements yield fractional kills of $E_1 = 0.72$ for phage A and $E_2 = 0.46$ for phage B. When both phages are applied together at the same MOIs as in the single-phage assays, the observed combined fractional kill is $E_{\\text{obs}} = 0.90$.\n\nAssume that, at the level of individual bacteria, the lethal actions of the two phages are independent events when co-applied, so that the probability a cell survives exposure to both equals the product of its probabilities of surviving each exposure alone. Starting from this independence principle and the definition of fractional kill, derive the expected combined fractional kill under independence and use it to compute the Bliss deviation, defined here as $D = E_{\\text{obs}} - E_{\\text{Bliss}}$.\n\nExpress your final numerical answer for $D$ as a decimal fraction with no percent sign. Round your answer to four significant figures.",
            "solution": "The problem requires the calculation of the Bliss deviation, a measure of interaction between two agents, in this case, two bacteriophages. The first step is to formalize the relationship between fractional kill and the probability of survival.\n\nLet $E$ be the fractional kill, which represents the fraction of the bacterial population eliminated. The fraction of the population that survives, $S$, is therefore the complement of $E$.\n$$\nS = 1 - E\n$$\nWe are given the fractional kills for phage A and phage B when applied separately:\n- For phage A: $E_1 = 0.72$\n- For phage B: $E_2 = 0.46$\n\nFrom these, we can calculate the corresponding survival fractions, which represent the probability that a single bacterium survives exposure to each phage individually:\n- Survival fraction from phage A: $S_1 = 1 - E_1 = 1 - 0.72 = 0.28$\n- Survival fraction from phage B: $S_2 = 1 - E_2 = 1 - 0.46 = 0.54$\n\nThe core assumption of the problem is that the lethal actions of the two phages are independent events. Under this assumption, the probability of a bacterium surviving exposure to both phages simultaneously is the product of the individual survival probabilities. This predicted survival fraction for the combination, under the model of independence (often called Bliss Independence), is denoted as $S_{\\text{Bliss}}$.\n$$\nS_{\\text{Bliss}} = S_1 \\times S_2\n$$\nThe expected combined fractional kill under this independence model, $E_{\\text{Bliss}}$, is the complement of the expected combined survival fraction.\n$$\nE_{\\text{Bliss}} = 1 - S_{\\text{Bliss}}\n$$\nBy substituting the expressions for $S_1$ and $S_2$ in terms of $E_1$ and $E_2$, we derive the general formula for the expected combined effect under Bliss Independence:\n$$\nE_{\\text{Bliss}} = 1 - (S_1 \\times S_2) = 1 - (1 - E_1)(1 - E_2)\n$$\nNow, we can substitute the given numerical values into this formula to calculate $E_{\\text{Bliss}}$.\n$$\nE_{\\text{Bliss}} = 1 - (1 - 0.72)(1 - 0.46)\n$$\n$$\nE_{\\text{Bliss}} = 1 - (0.28)(0.54)\n$$\nThe product of the survival fractions is:\n$$\n0.28 \\times 0.54 = 0.1512\n$$\nSo, the expected survival fraction under independence is $S_{\\text{Bliss}} = 0.1512$.\nThe expected fractional kill under independence is:\n$$\nE_{\\text{Bliss}} = 1 - 0.1512 = 0.8488\n$$\nThe problem defines the Bliss deviation, $D$, as the difference between the observed combined fractional kill, $E_{\\text{obs}}$, and the expected fractional kill under independence, $E_{\\text{Bliss}}$.\n$$\nD = E_{\\text{obs}} - E_{\\text{Bliss}}\n$$\nWe are given that the observed combined fractional kill is $E_{\\text{obs}} = 0.90$. We can now calculate the deviation $D$.\n$$\nD = 0.90 - 0.8488\n$$\n$$\nD = 0.0512\n$$\nThe problem requires the final answer to be rounded to four significant figures. The calculated value $0.0512$ has three significant figures (the digits $5$, $1$, and $2$). To express this with four significant figures, a trailing zero must be added.\n$$\nD \\approx 0.05120\n$$\nThis positive deviation indicates a synergistic interaction, meaning the observed combined effect is greater than what would be expected if the two phages acted independently.",
            "answer": "$$\\boxed{0.05120}$$"
        }
    ]
}